Similarly, Vigorelli et al. also reported the involvement of DNMTb-induced CXCR4 gene promoter methylation and gene repression in HG-treated cord blood-derived CD34+ stem cells and the bone marrow-derived CD34+ stem cells isolated from patients having coronary artery disease along with diabetes mellitus [43]. This evidence concerns the gene CXCR4 and diabetes mellitus.